A CALL FOR LARGE SCALE ANALYSIS OF OMICS DATA FOR DRUG-TARGET FINDING IN NEURODEGENERATIVE DISEASES

PND is launching a joint transnational call with the aim of improving the understanding of the complex and multifactorial pathogenesis of neurodegenerative diseases through multi-OMICS and Big Data approaches designed to find new drug targets and target biomarkers for the development of tailored and personalised treatment approaches.

The aim of the call is to establish a number of ambitious, innovative, multi-disciplinary and multi-national collaborative research projects that seek to improve the understanding of the complex and multifactorial pathogenesis of neurodegenerative diseases by applying multi-OMICs and Big data
approaches in order to generate useful information for the diagnosis, treatment, prognosis, and drug discovery of neurodegenerative diseases.
 

Proposals must focus on one or several of the following neurodegenerative diseases:
· Alzheimer's disease and other dementias
· Parkinson's disease and PD-related disorders
· Prion diseases
· Motor neuron diseases
· Huntington's disease
· Spinocerebellar ataxia (SCA)
· Spinal muscular atrophy (SMA)

Under this scheme, joint transnational research proposals can be funded for a period of up to three years. Proposals may be submitted by research groups working in universities or other higher education institutions, non-university public or private research organisations, hospitals and other health and social care settings, as well as commercial companies, in particular small and medium-size enterprises (SMEs). Collaborations with companies from outside the traditional medical sector (e.g. computing, artificial intelligence) are welcome.

Each proposal must involve a minimum of three and a maximum of six regular partners, including the coordinator, from at least three different countries participating in this call.

More instruction in the link below “Call text 2023”

In case of interest, both as possible coordinator or partner,  please click on "m'interessa" and we will contact you.